NewAmsterdam Pharma Company NV
NAMS34.300USD
+2.240+6.99%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
3.88BMarket Cap
LossP/E TTM
NewAmsterdam Pharma Company NV Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
45.56M
223.37%
EPS(YoY)
-2.56
-18.90%
Analyst Rating
BUY
2026-02-07
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
